Biologic Therapies in HIV-infected Patients with Psoriasis: An Italian Experience

MeSH terms

• Adalimumab / administration & dosage*
• Adalimumab / adverse effects
• Adult
• Aged
• Biological Products / administration & dosage*
• Biological Products / adverse effects
• CD4 Lymphocyte Count
• Dermatologic Agents / administration & dosage*
• Dermatologic Agents / adverse effects
• Etanercept / administration & dosage*
• Etanercept / adverse effects
• Female
• HIV Infections / diagnosis
• HIV Infections / immunology*
• Humans
• Immunocompromised Host
• Italy
• Male
• Middle Aged
• Psoriasis / diagnosis
• Psoriasis / drug therapy*
• Psoriasis / immunology
• Recurrence
• Remission Induction
• Severity of Illness Index
• Time Factors
• Treatment Outcome
• Tumor Necrosis Factor-alpha / antagonists & inhibitors*
• Tumor Necrosis Factor-alpha / immunology
• Ustekinumab / administration & dosage*
• Ustekinumab / adverse effects
• Viral Load